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Background: Mothers are at risk of domestic violence (DV) and its harmful consequences postpartum. There is no
evidence to date for sustainability of DV screening in primary care settings. We aimed to test whether a theory-informed,
maternal and child health (MCH) nurse-designed model increased and sustained DV screening, disclosure, safety planning
and referrals compared with usual care.
Methods: Cluster randomised controlled trial of 12 month MCH DV screening and care intervention with 24 month
follow-up.
The study was set in community-based MCH nurse teams (91 centres, 163 nurses) in north-west Melbourne, Australia.
Eight eligible teams were recruited. Team randomisation occurred at a public meeting using opaque envelopes. Teams
were unable to be blinded.
The intervention was informed by Normalisation Process Theory, the nurse-designed good practice model incorporated
nurse mentors, strengthened relationships with DV services, nurse safety, a self-completion maternal health screening
checklist at three or four month consultations and DV clinical guidelines. Usual care involved government mandated
face-to-face DV screening at four weeks postpartum and follow-up as required.
Primary outcomes were MCH team screening, disclosure, safety planning and referral rates from routine government
data and a postal survey sent to 10,472 women with babies ≤ 12 months in study areas. Secondary outcomes included
DV prevalence (Composite Abuse Scale, CAS) and harm measures (postal survey).
Results: No significant differences were found in routine screening at four months (IG 2,330/6,381 consultations
(36.5 %) versus CG 1,792/7,638 consultations (23.5 %), RR = 1.56 CI 0.96–2.52) but data from maternal health checklists
(n = 2,771) at three month IG consultations showed average screening rates of 63.1 %. Two years post-intervention, IG
safety planning rates had increased from three (RR 2.95, CI 1.11–7.82) to four times those of CG (RR 4.22 CI 1.64–10.9).
Referrals remained low in both intervention groups (IGs) and comparison groups (CGs) (<1 %).
2,621/10,472 mothers (25 %) returned surveys. No difference was found between arms in preference or comfort with
being asked about DV or feelings about self.
Conclusion: A nurse-designed screening and care model did not increase routine screening or referrals, but achieved
significantly increased safety planning over 36 months among postpartum women. Self-completion DV screening was
welcomed by nurses and women and contributed to sustainability.
Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12609000424202, 10/03/2009
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Women abused by partners in their reproductive years,
especially those pregnant and with infants, are vulnerable
to adverse physical and mental health consequences,
which can also affect parenting [1, 2] and infants [3]. Some
governments mandate universal domestic violence (DV)
screening in all health care settings as a solution, an issue
which remains keenly debated [4–6]. While there is evi-
dence that screening increases identification, there is
no rigorous evidence to date that it increases referrals,
reduces abuse or improves women’s health or safety [7, 8].
Selective screening for vulnerable populations, such as
pregnant women, has been recommended, but not yet for
postpartum women, and the postpartum period is a time
of increased stress [9]. There is also no evidence for
sustainability of health professional screening. Rates are
low, with a synthesis of reported screening rates from chart
review, provider and patient surveys finding low median
screening rates of 15.5 % to 22.7 % [10]. When assessing
the effectiveness of interventions for women experiencing
DV, intermediate primary outcomes such as disclosure and
increased safety planning discussions may be more achiev-
able and meaningful measures than a reduction in abuse
[11, 12]. Effective safety planning with women by health
care professionals is crucial, as women may not be ready to
accept specialist intimate partner violence (IPV) services at
disclosure [13, 14] and safety planning increases women
taking measures to enhance their safety [15, 16].
The Australian government has policies, funding and
services to tackle DV at both federal and state levels. In
2009, the Victorian state government developed a coor-
dinated response that included one-off DV case-finding
training with a gender-based framework for DV workers,
police, court staff and health providers including maternal
and child health (MCH) nurses. The training and its asso-
ciated manual [17] included strategies for identification,
safety planning and referral.
In Victoria, MCH services are funded by state and local
governments and provided by nurse-midwives, who work
mostly in community-based teams. Within their teams, one
or two MCH nurses are based in local centres with ap-
proximately ten centres and 15 to 20 MCH nurses in total
per team. MCH teams have a coordinator who manages
the team. MCH nurses provide postpartum care to over
95 % of all recent mothers and babies and follow-up care
for children to six years of age in local centres at scheduled
visits. In 2009, the state government restructured overall
MCH nursing to include mandating that all MCH nurses
screen for DV when babies are four weeks old and if
appropriate again at later visits [18, 19]. All MCH nurse
teams received the one-off DV training as part of the
government’s integrated response and a manual with rec-
ommended screening questions. While MCH nurses
are ideally placed to identify and support abused recentmothers, feedback from nursing colleagues suggested
that there were problems with the proposed screening
program. We therefore considered that screening effective-
ness and improved care for abused women may not be
achieved unless routine screening and subsequent practices
are responsive to nurses’ concerns (for example, about their
own safety, women’s reluctance to act) and sustained within
everyday routine care.
Our aim was a) to test a theory-informed MCH nurse-
designed model of care to increase MCH team screening
rates, disclosure, safety planning and referrals over 12
months, compared with teams implementing government
mandated care and b) to test independent program sustain-
ability 24 months later. This paper reports the primary and
secondary outcomes for the first year and the 24 month
follow-up of primary outcomes.
Hypothesis and objectives
We hypothesised that by implementing the new nurse-
designed, theory-informed model of DV screening and
care we could achieve the following: at the end of 12
months, the intervention teams would achieve higher
rates of screening, disclosure, safety planning and re-
ferrals than comparison teams providing usual care;
and that findings would be sustained after 24 months.
We pre-specified the following primary outcomes [20].
Relative to comparison teams, intervention teams would
demonstrate an increase in
1. Women screened for DV
2. Women’s disclosure and nurse safety planning
3. Referrals
Secondary outcomes were:
1. Prevalence of any DV in the previous 12 months
(Composite Abuse Scale [21], ≥ 3–6, and ≥ 7), DV
during pregnancy and maternal reporting of abuse
as a child
2. No difference in proportions of women reporting
harm
Methods
Trial design
Our protocol and the development of the intervention
are more fully described elsewhere [20]. The Improving
Maternal and Child Health Care for Vulnerable Mothers
(MOVE) project was a cluster randomised trial with MCH
teams the unit of randomisation, as the intervention aimed
to alter DV screening and care practice across the whole
MCH team, not only at the centre or individual nurse level.
We also randomised at team level to minimise contamin-
ation across centres. We involved eight teams previously
randomised in 2005 for a trial (Mothers’ Advocates In the
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The MOSAIC DV trial tested a non-professional, mother-
to-mother support intervention for pregnant or abused
recent mothers. MCH nurses participated by recruiting
women they had identified into the peer support program.
Despite six hours of DV training, nurse identification of
abused women was low. In process evaluation, nurses re-
quested improved ways of working to identify and support
women and children experiencing violence. MOVE devel-
oped from this previous trial [22].
Randomisation and masking
MOSAIC study randomisation had involved the eight
MCH teams stratified by size (numbers of births per
annum) using opaque envelopes. Selection was made at a
public forum by someone outside the study team. To build
on MCH nurse feedback from the MOSAIC trial, all eight
teams were recontacted in 2009 to participate in a follow-
up study with reverse randomisation (previous intervention
teams would become comparison teams and vice versa).
Managers of MCH teams gave consent through new signed
Memoranda of Understanding on behalf of the eight MCH
teams for this MOVE study and to participate in reverse
randomisation. Blinding of MCH teams to intervention
status was not possible given the participatory nature of
the intervention with MCH nurses in the intervention arm
engaged in design and delivery of the model, but mothers
attending were blinded.
Participants
Participants included eight MCH teams in the disadvan-
taged north-west suburbs of Melbourne [22]. Four inter-
vention and four comparison teams and the postpartum
women with babies ≤ 12 months who attended them
participated. The intervention was delivered to postpartum
women attending intervention centres at scheduled visits
over one year.
Intervention
Intervention development
MOVE model development commenced on 30 June 2009
with four intervention team nurse consultants. Normalisa-
tion Process Theory (NPT) [23] was the theoretical frame-
work for the design, implementation and evaluation of the
MOVE model, as it aims to strengthen sustainability in
health care behaviours, work practices and systems. NPT is
based on sociological theory that extends individual ex-
planation of behaviours to predict facilitators and barriers
to ‘normalisation’ of new clinical practices. The theory con-
ceptualises types of ‘work’ required for implementation,
embedding and integration of complex interventions.
The participatory research process involved all-day meet-
ings between intervention team nurse consultants and
research staff held each month for six months duringthe development phase to discuss and conceptualise
perceived nurse DV screening and care problems and
solutions using the NPT framework. Following the meeting,
each nurse consultant discussed strategies within their own
team to improve DV practice by individual nurses, their
team and their local government employer and brought
them back for discussion. Along with the action research, a
systematic search was undertaken of controlled interven-
tions and evidence-based guidelines that aimed to improve
clinician responses to abused women and their children.
Findings were shared with advisory group members and
nurse consultants, to facilitate development of the MOVE
clinical resources. Evidence suggested that women prefer
self-completion screening methods rather than face-to-
face/direct asking [24]. This informed the design and
use of the self-completion maternal health checklist used
at three to four months. Utilising results from the unpub-
lished evidence review of the community nursing DV
practice and iterative development process, nurse consul-
tants and research staff jointly designed the consensus
model described below.The MOVE intervention
The enhanced screening and care model included nurse
mentors, designated DV regional liaison workers based
in DV services, a self-completion maternal health and
wellbeing checklist and a clinical pathway and guidelines
[20]. The checklist asked questions about physical symp-
toms, for example, sore nipples and backache, as well as
DV questions asked face to face by nurses in the com-
parison arm and outlined below. Nurse mentors’ roles
included assisting with nurse safety (for example, ac-
companying nurses home visiting where violence was
suspected), supporting colleagues with difficult consul-
tations and enhancing liaison with DV services. Additional
MOVE screening was implemented later than mandated, at
a non-routine specific maternal health visit at three months
in three teams. Additional local government funding
had to be found for these visits. In one team, 15 minutes
was added instead to the funded routine four month visit.
Research staff visited intervention teams once to bring
resources, outline yearlong intervention processes and
introduce the DV service liaison worker. Research staff
administered an online survey for nurses at six to eight
months into, and three months after the intervention
period (process and impact evaluation) and collected
checklists quarterly. The intervention period was 1 April
2010 to 31 March 2011.Supplementary intervention checklists The checklist
included DV questions asked face to face by nurses in
the comparison arm (outlined below) with the following
additions:
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intimacy with your partner?
 Has anyone in your household ever humiliated you
or tried to control what you can or cannot do? (This
was recommended in training but not in the MCH
manual.)
Women were provided with the checklist at the com-
mencement of the three or four month visit and encour-
aged to complete it themselves while nurses cared for
the child. Nurses responded to women’s self-identified
concerns in the checklist but responses to the intimate
relationship and violence questions were addressed first.
Usual care Comparison and intervention teams were
both trained and mandated to undertake universal DV
screening at four weeks postpartum using recommended
standard questions suggested in the MCH service practice
guidelines [18] which covered abuse broader than that
from an intimate partner:
 Are you in any way worried about the safety of
yourself or your children?
 Are you afraid of someone in your family?
 Has anyone in your household ever pushed, hit,
kicked, punched or otherwise hurt you?
Comparison teams did not use self-completion checklists
for screening or any other elements of the MOVE model.
Screening occurred only via face-to-face nurse questioning
as mandated at four weeks and at other times if considered
necessary.
Ethics
Informed consent was negotiated at the MCH team level
and supported by a written Memorandum of Under-
standing to participate. Women were unaware of their
nurse’s participation in the trial and women’s return of
the survey questionnaire was regarded as consent to par-
ticipation in the survey. The study was approved by the
Human Ethics Committee, La Trobe University (UHEC
08-142) and also by the University of Melbourne and the
Victorian Government Department of Education and
Early Childhood Development (ADD/07/6733).
Outcome data collection
Routinely collected MCH data
MCH nurses routinely complete anonymised and compu-
terised reports on each episode of DV screening, safety
planning and referral, and data are collated annually by
each team in report form to the Department of Education
and Early Childhood Development. These data were ex-
tracted by all eight MCH teams’ administrative staff for
the full 12 months of the intervention period, and at threemonths afterwards, and forwarded to the research team.
These same data were later also requested for the two year
post-intervention (1 April 2011 to 31 March 2013).
Specifically, the data included a) the numbers of
women screened and all consultation numbers, regarded
as opportunities to screen (denominator) at four weeks,
four months and twelve months; b) numbers of reported
safety plans; and c) numbers of referrals for the year and
all active infant records representing all those who had
attended local government MCH centres (denominator)
for both arms of the study.Supplementary intervention checklists
In the intervention arm, MOVE maternal health screening
checklists were collected quarterly from specified collec-
tion boxes. Although checklists were to be completed at
the three or four month maternal health visits, some were
returned that were completed at other time points. Only
those recorded at three or four month visits as intended
and those fully completed (2,771/4,152) were retained for
analysis. Maternal health checklist use and DV screening
at three months could not be assessed for the 24 months
follow-up period, as MCH teams do not routinely collect
and report any three month data.Women’s survey
To achieve β of 0.20 and α at 0.05, the survey sample
size (n = 10,000) assumed an 8 to 10 % DV prevalence
to predict a 15 % increase in disclosure, taking into ac-
count birth rate per team, a 55 % response rate, clustering
of clients and an intra-cluster correlation (ICC) of 0.02
from a previous study [20]. Outcomes from client perspec-
tives were measured by anonymous surveys (n = 10,472)
about recent mothers’ emotional health. These were
mailed in June 2011 by an external data capture company
blinded to the study arm to all women who had given
birth between 1 May and 31 December 2010, in order to
reach the required sample size (when babies were between
6 and 12 months old). DV was measured using the well-
validated Composite Abuse Scale (CAS) [21] with recom-
mended cut-off scores - low levels (a score of 3 to 6) and
high (a cut-off of ≥ 7) considered probable and confirmed
DV. The survey also asked women whether the nurse
inquired about a range of maternal health issues, in-
cluding DV, during any of the visits, whether the topic
was discussed and whether affected women were re-
ferred. Other measures included three items from the
Consequences of Screening Tool (COST), a measure of
harm from screening [25].
Surveys were returned to the data entry company,
cleaned, coded and double-entered into a secure database
by company staff blinded to the trial arm and then for-
warded to the study statistician, also blinded.
Maternal and Child Health Teams 
assessed for eligibility (n=8)
Randomised (n=8)
Allocated to MOVE 
intervention teams (n=4)
Received allocated 
intervention 
No. Centres=50
No. Staff=80
Allocated to comparison 
teams (n=4)
Screening and care as 
usual
No. Centres=41
No. Staff=83
No team loss to follow-up No team loss to follow-up
Analysed:
Consultations (n=55,810)
Consultations about infants 
≤12months   (6447)
Analysed:
Consultations (n=69,345)
Consultations about infants 
≤12months   (9099)
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Using routine data at all time points, relative risks between
arms were estimated using binomial regression, adjusting
for clustering of observations at team level and stratified
by time for the proportion of a) women screened (four
weeks and four months), b) reports of nurses discussing
safety plans and c) reported referrals.
In the intervention arm only, we also calculated the
checklist screening proportions by time point (three or
four months). The one team using the checklist at an ex-
tended routine four month visit provided screening data
at this time point to be compared with the comparison
team average post-intervention.
For survey respondents, women’s socio-demographic
and birth characteristics were compared by trial arm to
assess the effectiveness of randomisation. Respondent
representativeness was assessed by comparison with avail-
able Victorian Perinatal Data Collection routine data for
all women giving birth in the region.
An intention to treat [26] analysis was undertaken to
estimate risk ratios with robust variance estimation to
adjust standard errors for clustering of study participants
within teams. We used contingency table analyses for
bivariable and generalised linear modelling (specifying a
binomial distribution and log link function) for multivari-
able models. For primary outcomes as pre-specified, data
were adjusted for women’s abuse status and for confound-
ing variables, including women’s socio-economic status.
All data were analysed using STATA 11 [27].Women attended (n=22, 888)
Client surveys (n=1269)
Women attended (n= 22, 719)
Client surveys (n=1352)
Fig. 1 Flow diagram for MOVE maternal and child health
nurse teamsResults
There were four MCH teams in each trial arm and roughly
equal numbers of centres (IG 50: CG 41) and staff (IG 80:
CG 83). Fig. 1 (a flow diagram) shows that while MOVE
intervention teams had fewer consultations/opportunities
to screen (IG 55,810 versus CG 69,345) in the intervention
period, approximately the same number of recent mothers
attended MCH centres (IG 22,888 versus CG 22,719), but
there were fewer consultations with women whose babies
were ≤ 12 months in the intervention (n = 6,447) than the
comparison (n = 9,099) arm.
The characteristics of all eight MCH teams were
broadly representative of Victorian MCH teams (Table 1).
The majority of MCH nurses were part-time, 46 to 55
years old with tertiary qualifications, although MOVE
intervention nurses were slightly better qualified.
Table 2 shows the routine screening, safety planning
and recorded referrals for the 12 month intervention
period (2010–2011) and the 24 month follow-up (2011–
2012, 2012–2013).
Routine screening gradually increased with the highest
four week screening point reaching 56 %, but no year-
long rate reached above 36 %.Intervention period (2010–2011) routine data
There were no differences between arms in routine re-
ported screening rates at mandatory four week consul-
tations (Adj RR 0.87, CI 0.64–1.19). While there were
no statistically significant differences at the routine four
month consultations (Adj RR 1.56, CI 0.96–2.52), MOVE
teams recorded screening in higher proportions (IG 36.5 %
versus CG 23.5 %).
There was a significant increase in intervention teams
reported safety planning (Adj RR 2.95, CI 1.11–7.82)
compared with comparison teams (Table 2). There was
no difference in recorded referrals, and numbers were
small (Adj RR 0.88, CI 0.36–2.14).
Intervention checklist data: screening at 3 to 4 months
The three month intervention team checklist data (Table 3)
showed that MOVE nurses in these three teams screened
63.1 % (team range: 53.9 % to 89 %) of women. For the
one team that reported four month routine screening at
Table 1 Characteristics of MCH nurses in MOVE and
comparison teams
MOVE teams
(n = 80) %
Comparison teams
(n = 83) %
Victoria
(%)
Employment status (%) n = Effective Full Time
Full time 25 29 20.8
Part time 66 69.9 70.5
Permanent reliever 8.8 1.2 8.7
Age (%) n = 72 n = 82
<45 9.7 13.4 16
46-55 55.6 46.3 52
>56 34.7 40.2 33
Qualifications (%)
Certificate/diploma 7.5 15.7 19.8
#Degree/graduate
diploma/masters
93 84.3 81
Roles (%)
Universal 84.2 81.7 77.1
Coordinators 8.4 4.6 8.0
*Enhanced Home
Visitors
4.5 8.1 7.8
Non-MCH staff 2.9 5.7 5.7
*MCH nurses targeting vulnerable families
#No statistically significant differences in higher qualification level between groups
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health screening), the 53.9 % screening rate exceeded the
average comparison team rate of 23.5 %.
Twenty four month follow-up period (2011–2013) routine
data
The intervention did not significantly affect the routinely
reported screening rates of MCH teams in either arm of
the study at four weeks, four months or yearlong screen-
ing at 12 and 24 months post-trial. However, compared
with safety planning during 2010–2011, intervention
group safety plans increased more than threefold (Adj
RR 3.37, CI 1.24–9.19) and fourfold (Adj RR 4.22, CI
1.64–10.9) that of comparison teams where there was no
reported change. Referrals did not differ by trial arm at
any time over three years and were all below 1 %.
Women's survey data
2,621/10,472 (25 %) mailed surveys were returned.
There were no significant differences in proportions of
abused women (IG 6.5 % versus CG 7.1 % CAS ≥ 7) or
in socio-demographic characteristics between arms
(Table 4), although compared with Victorian birth data,
fewer immigrant women from non-English-speaking coun-
tries responded. Among these recent, mostly primiparous
mothers (mean age 34), 6.8 % reported domestic violence
(CAS ≥ 7) and 7.1 % probable abuse (CAS 3-6) — a totalof 13.9 %. 11.1 % reported being currently (1.6 %) or ever
(9.5 %) afraid of a partner, 2.8 % had experienced violence
during pregnancy and 10.3 % reported abuse by other
partners.
Table 5 outlines survey data estimates. While there
were no differences between arms in women’s reports of
nurses asking most mandated screening questions (Adj
RR 1.09, CI 0.89 –1.34), intervention respondents
recalled nurses asking about relationships (Adj RR 1.27,
CI 1.03–1.58) and the question about coercion by part-
ners (Adj RR 1.52, CI 1.19– 1.95) significantly more fre-
quently than comparison arm respondents. DV
disclosure/discussions with nurses were reported more
frequently in the intervention arm, but differences did
not reach statistical significance. Numbers of referrals
among women disclosing proved to be too few to be
analysed. There were no differences between arms in the
proportions of women expressing discomfort about
speaking about abuse (Adj RR 0.96, CI 0.73 –1.25), an-
swering questions about abuse (Adj RR 0.95, CI 0.84–
1.07) or feeling worse about themselves as a result (Adj
RR 0.98, CI 0.82–1.16).
Discussion
The MOVE intervention (nurse mentors; strengthened
relationships with DV services; nurse safety; a self-
completion maternal health screening checklist at three
or four month consultations; DV clinical guidelines) had
no effect on routinely (four week, four month) reported
DV screening rates or on referrals. However, safety plan-
ning increased significantly and was sustained and more
frequent over the three years. MOVE is the first DV
screening trial to provide evidence of sustained clinician
domestic violence screening behaviour. While there was
no significant difference in screening rates in routine
visit reporting, there was a fourfold increase screening
rate indicated from continued use of the self-completion
checklists in the intervention arm, compared with the
mean rate in usual care, something which suggests that
use of the checklist provided greater opportunity for DV
discussions to occur. MOVE process evaluation identi-
fied implementation barriers, such as lack of nurse re-
flective practice and the coinciding introduction of a
new practice framework [28]. However, intervention
team nurses reported continued high use of the checklist
(81 %) and non-routine maternal health visits. This might
account for the between-group difference in safety-
planning rates, despite suboptimal screening rates at
routinely recorded visits.
Screening rates of greater than 50 % at 36 months in
both arms is a significant improvement on previously re-
ported rates [10]. While DV screening increased over
time in both arms, we can see from the comparison
group that screening alone did not improve outcomes
Table 2 Maternal and child health team screening, safety planning and referral rates over three years
MOVE intervention group Comparison group Effect of the intervention
Screening year and
time point
Number
consults
Number
screened
%
screened
Number
consults
Number
Screened
%
screened
RR 95 % CI P-value
Screen at 4 weeks
Year 1 2010–2011 6,593 2,447 37.1 7,979 3,408 42.7 0.87 0.64 – 1.19 0.4
Year 2 2011–2012 6,751 2,907 43.1 8,334 4,243 50.9 0.85 0.68 – 1.05 0.1
Year 3 2012–2013 6,766 3,424 50.6 8,643 4,866 56.3 0.90 0.73 – 1.11 0.3
Screen at 4 months
Year 1 2010–2011 6,381 2,330 36.5 7,638 1,792 23.5 1.56 0.96 – 2.52 0.07
Year 2 2011–2012 6,358 1,712 26.9 7,753 2,404 31.0 0.87 0.60 – 1.25 0.5
Year 3 2012–2013 6,546 1,869 29.0 8,589 3,080 35.9 0.80 0.52 – 1.23 0.3
Yearlong screening
Year 1 2010–2011 55,810 10,963 19.6 69,345 17,197 24.8 0.79 0.46 – 1.35 0.4
Year 2 2011–2012 57,221 12,195 21.3 71,004 21,926 30.9 0.69 0.43 – 1.10 0.1
Year 3 2012–2013 58,464 14,608 25.0 75,807 26,908 35.5 0.7 0.45 – 1.10 0.12
Safety planning
Year 1 2010–2011 22,888 962 4.2 28,215 402 1.4 2.95 1.11 – 7.82 0.03
Year 2 2011–2012 23,780 1,218 5.1 28,163 428 1.5 3.37 1.24 – 9.19 0.02
Year 3 2012–2013 24,656 1,452 5.9 29,762 415 1.4 4.22 1.64 – 10.9 0.003
Referrals
Year 1 2010–2011 22,888 143 0.6 28,215 201 0.7 0.88 0.36 – 2.14 0.8
Year 2 2011–2012 23,780 147 0.6 28,163 225 0.8 0.77 0.35 – 1.71 0.5
Year 3 2012–2013 24,656 225 0.9 29,762 263 0.9 1.03 0.60 – 1.79 0.9
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[14] propose that referrals may be neither a desired nor
an appropriate goal for women in pre-contemplative or
contemplative phases of the abuse cycle. Intermediate
goals such as safety planning may offer improved care
for postpartum women who may use more safety behav-
iours [16], but more research is required to understand the
immediate and longer term benefits of safety planning [11].Table 3 Additional screening conducted in intervention arm
with maternal health checklists
MOVE
team
N Screened/
consultations
% and time
point
Comparison teams
4 month average
1 498/805 61.9 %
(3 months)
2 1,021/1,894 53.9 %
(4 months)
1,792/7,638 23.5 %
3 710/798 89 %
(3 months)
4 542/896 60.5 %
(3 months)
Total 2,771/4,393 63.1 %
(mean)
(One team compared with routinely reported comparison mean screening rate
at four months)The first strength of this study lies in the theory-in-
formed, nurse-designed consensus model, which enhanced
ownership, participation and potential sustainability of the
intervention. The study’s participatory development phase
firmly identified that nurses wanted a later (three or four
month) screening time focussed on the mother and her
needs, as a) there would be less likelihood of her partner at-
tending; b) she would have recovered from the birth and be
more able to focus on her own needs, not just the baby’s; c)
they could establish trust prior to screening. Nurses re-
ported both themselves and women as being more
comfortable with the self-completion checklist, as other
studies have also shown [29]. The checklist allowed
women experiencing DV to reflect whether or not they
wished to disclose at this consultation or at all, and the
nurse was not responsible for raising the issue, which
both nurses and women may find confronting. Nurses
surmised that some women raised relationship issues
with possible later disclosure in mind. If mothers were
not abused, nurses expressed satisfaction with being
able to discuss other maternal health issues, such as in-
continence problems or contraception, which women
may not otherwise have raised.
The MOVE trial is the first study to examine the sus-
tainability of nurse DV screening and support using a
Table 4 Characteristics of MOVE survey respondents by arm
(n = 2,621) compared with regional women giving birth
Characteristic Comparison
group
MOVE
group
2009 perinatal
regional data
n = 1,352 (%) n = 1,269 (%) n = 9,886 (%)*
Mean age (SD) 34 (4.6) 34.1 (4.5) 31.5 (5.3)
Birthplace
• Australian born 66.3 68.6 59
• Overseas born 33.7 31.4 41
Permanent resident
• No 11.6 15.7
Marital status
• Married 78.7 78.1 76
Year left school
• Completed year 12 89.8 91.1
• Year 11 or less 9.1 8.3
• Primary only or no
school
1.1 0.6
Further education
• Degree/higher
degree
60.6 64.3
• Diploma/
apprenticeship
24.5 22.3
• None 14.9 13.4
Employment
• Paid work 51.8 53.6
• Study 3.4 4.1
• Study/work 2.3 2.9
• Unemployed 29.1 26.1
• Unpaid work 13.5 13.4
Parity (primiparous) 54 54.3 47
Health Care Card (low income)
• Yes 18.1 15.5
Family income (AUD)
• ≤50,000 22.1 17.4
• ≤70,000 17.6 17.1
• >70,000 60.3 65.4
Prevalence of IPV among MOVE survey respondents Total
Intimate partner violence (CAS)
• 3–6 7.2 7.0 7.1
• ≥7 7.1 6.5 6.8
Total abused 14.3 13.5 13.9
Fear of partner
• Current/ex 1.9 1.4 1.6
• Ever afraid 9.7 9.4 9.5
IPV in pregnancy (recent or past pregnancy)
• Yes 2.8 2.8 2.8
Table 4 Characteristics of MOVE survey respondents by arm
(n = 2,621) compared with regional women giving birth
(Continued)
Abuse by other partners
• Yes 10.7 9.9 10.3
Childhood abuse
• Yes (physical, sexual
or emotional)
17.5 18.1 17.8
*Victorian Perinatal Data Unit
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[7, 30]. A further strength is the length of follow-up and
the fact that no clusters, although there were only a few,
were lost. The use of routine data records meant that all
women giving birth in the previous 12 months and all
consultations were included. A limitation is the depend-
ency on routine data accuracy, but any errors are likely
to be randomly distributed across study arms. Generalis-
ability to all community MCH nurses will be limited due
to DV training for all eight MCH teams from the previous
study [22]. However, with the use of NPT (or without), at-
tention to the nursing specific context, individual and nurse
team needs, to self-completion screening methods (includ-
ing computerised methods) and to nurses’ own safety are
generalisable lessons for sustained screening improvement
that can be drawn from this trial. A further lesson isTable 5 Women’s reports of being asked about domestic
violence and harm by trial arm: percent (%), adjusted relative
risk ratio (Adj RR) and 95 % confidence interval (95 % CI) (n = 2,621)
Screening MOVE
(%)
Comparison
(%)
*Adj
RR
95 % CI†
Asked about family violence
(physical violence, safety, fear)?
47.6 41.7 1.09 0.89–1.34
Humiliate or tried to control
you?
32.2 19.7 1.52 1.19–1.95
Problems in your relationship
or intimacy with your partner?
44.8 34.3 1.27 1.03–1.58
Harm questions adapted from
COST
I would have preferred not to
speak about some of my
concerns about my partner
with the MCH nurse-(agree/
somewhat agree)
13.2 14.8 0.96 0.73–1.25
Because of the attitude of the
MCH nurse towards me, my
feelings about myself are-
(worse/somewhat worse)
1.9 1.5 0.98 0.82–1.16
In answering the questions
about my partner and any
violent behaviour, I felt-
(uncomf/somewhat
uncomfortable)
3.1 4.1 0.95 0.84–1.07
*Risk ratios adjusted for abuse (CAS ≥ 7), income, health care card and education
†Robust standard errors adjusted for Local Government Area clustering
Taft et al. BMC Medicine  (2015) 13:150 Page 9 of 10the need for continued upskilling identified by nurses
in evaluative feedback. Online and web-based learning
can offer this when nurses have time to complete it.
Survey data are limited by the low response fraction,
now a common problem for many postal surveys, espe-
cially with younger people [31]. Similar to other mailed
surveys, respondents had quite high socio-economic sta-
tus [32]. However, while this limits generalisability, the
prevalence we found is similar to another Victorian
population study but is liable to be an under-estimate of
DV in both [33]. Reassuringly, there was no harm from
the intervention itself, as there were no differences be-
tween arms in women reporting discomfort in being asked
about or responding to questions concerning abuse, al-
though it is noteworthy that more than one in ten survey
respondents would have preferred not to be asked about
abuse. A small proportion of women felt worse off after
the consultation with the nurse, but this may occur with
any consultation.
Randomisation did result in three MCH teams being in
one region (with only one advocate), while the remaining
team was in another region and also had one advocate.
This latter team had the most successful outcomes for
screening and safety planning, suggesting that a higher
‘dose’ of DV advocacy/liaison may have had a positive
impact on team confidence, if not on referrals.
Conclusion
MOVE has demonstrated that DV safety planning rates
can be improved and sustained over 36 months. This
was achieved with a nurse-designed model of screening
and care, including DV inquiry via use of self-report
(checklist) disclosure rather than direct questioning in
this vulnerable population of postpartum mothers. We
recommend that greater attention be given to how
screening is implemented in primary care and that fur-
ther research be undertaken on intermediate outcomes
such as safety planning and its benefits. The involvement
of staff is critical both for effectiveness and sustainability
of DV interventions in health care settings.
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